TENANTS

Author Archive | Allen

ARROWHEAD-BUILDING

Arrowhead Pharmaceuticals inks $250M deal with Janssen Pharmaceuticals that could grow to $3.7B

Arrowhead Pharmaceuticals says it has reached a licensing and collaboration agreement with Janssen Pharmaceuticals that will bring the company $250 million to start and ultimately could be worth as much as $3.7 billion. Janssen will get the worldwide exclusive license for ARO-HBV, a drug that treats chronic hepatitis B, and an option to collaborate with […]

Continue Reading
innovation-awards

Wisconsin Innovation Awards Announce 2018 Winners at Annual Ceremony in Madison

Ten winners winners were honored from the thirty-three finalists and more than 350 nominees during the 2018 Wisconsin Innovation Awards at the Wisconsin Union Terrace. The ceremony, emceed by local entrepreneur and Filament Games Vice President of Sales, Jennifer Javornik recognized the state’s most innovative products and services from nine industry categories. The 2018 winners […]

Continue Reading
Screen Shot 2018-10-03 at 4.39.25 PM

Raman Earns Prestigious NIH Award to Fund Research on Protein Function

Biochemistry assistant professor Srivatsan “Vatsan” Raman has received a Director’s New Innovator Award from the National Institutes of Health (NIH). The $2.2 million-grants fund high-risk, high-reward research performed by early stage investigators. Compared to traditional NIH grants, the New Innovator Award supports “unusually creative early stage investigators” whose research can have a broad impact on biomedical sciences. Raman’s project is focused […]

Continue Reading
FluGen_weblogo

Children are the latest test subjects of FluGen’s universal flu vaccine

An influenza vaccine developed by FluGen, of Madison, is being tested on children and teenagers in a clinical trial that’s being subsidized by a division of the National Institutes of Health. The test began in August, according to a statement last week by the National Institute of Allergy and Infectious Diseases. Fifty healthy children between […]

Continue Reading
D2P Innovation to Market

Discovery to Product creates new program to grow entrepreneurship at UW–Madison

Discovery to Product, which supports and mentors faculty, staff and student innovators and entrepreneurs on campus, is offering a new program called Innovation to Market. The fall I2M program builds on the success of D2P’s Igniter program cohorts that helped start 19 companies over the past three years. “The goals of D2P, located within the […]

Continue Reading
all-of-us-madison

‘All of Us Research’ Program reaches 100,000 participants

The All of Us Research Program reached an important milestone, enrolling 100,000 participants nationwide in its historic journey to positively impact the future of health research and treatment for generations. The All of Us Research Program at the University of Wisconsin-Madison, which is part of a Wisconsin consortium, including Marshfield Clinic, the Medical College of […]

Continue Reading
NeuroPoint

NeuroPointDX Biological test for autism could lead to earlier identification

A new study from NeuroPointDX of Madison and University of California researchers shows biochemical markers could allow for earlier identification of autism spectrum disorder. Lead author David Amaral says this discovery could also lead to avenues for therapeutic intervention. NeuroPointDX is a division of Stemina Biomarker Discovery, also based in Madison, and Amaral is from […]

Continue Reading
MG_0058-500x333

Initiative focuses on advanced technology innovations in biomanufacturing

A $750,000 grant from the Wisconsin Economic Development Corp. announced today (Sept. 6) establishes the Forward BIO Initiative, a collaborative effort to make Wisconsin a recognized center of excellence for biomanufacturing. The new initiative “leverages one of our key long-term strengths at UW, which is working at the crossroads where multiple disciplines connect,” UW–Madison Chancellor […]

Continue Reading